Abstract
Importance The current wave of COVID-19 infections has led to media reports of ICUs across the country reaching critical capacity. But the degree to which this has happened and community and institutional characteristics of hospitals where capacity limits have been reached is largely unknown.
Objective To determine changes in intensive care capacity in US acute care hospitals between September and early December, 2020 and to identify whether hospitals serving more vulnerable populations were more likely to exceed critical-levels of ICU occupancy.
Design, Setting, and Participants Retrospective observational cohort of US acute care hospitals reporting to the US Department of Health and Human Services (HHS) from September 4, 2020 to December 3, 2020. Hospitals in this cohort were compared to all US acute care hospitals. Multivariate logistic regression was used to assess the relationship between community socioeconomic factors and hospital-structural features with a hospital reaching critical ICU capacity.
Exposure Community-level socioeconomic status and hospital-structural features
Main Outcomes and Measures Our primary outcome was reaching critical ICU capacity (>90%) for at least two weeks since September 4. Secondary outcomes included the weekly capacity and occupancy tabulated by state and by hospital referral region.
Results 1,791 hospitals had unsuppressed ICU capacity data in the HHS Protect dataset, with 45% of hospitals reaching critical ICU capacity for at least two weeks during the study period. Hospitals in the South (OR = 2.79, p<0.001), Midwest (OR = 1.76, p=0.01) and West (OR = 1.85, p<0.01) were more likely to reach critical capacity than those in the Northeast. For-profit hospitals (OR = 2.15, p<0.001), rural hospitals (OR = 1.40, p<0.05) and hospitals in areas of high uninsurance (OR = 1.94, p<0.001) were more likely to reach critical ICU capacity, while hospitals with more intensivists (OR = 0.92, p=0.044 and higher nurse-bed ratios (OR = 0.95, p=0.013) were less likely to reach critical capacity.
Conclusions and Relevance Nearly half of U.S. hospitals reporting data to HHS Protect have reached critical capacity at some point since September. Those that are better resourced with staff were less likely to do so while for for-profit hospitals and those in poorer communities were more likely to reach capacity. Continued non-pharmacologic interventions are clearly needed to spread of the disease to ensure ICUs remain open for all patients needing critical care.
Question With an increasing number of SARS-CoV2 infections, how has the burden on ICU capacity changed over the past three months and what community and institutional factors are associated with hospitals reaching critical capacity?
Finding 45% of US acute care hospitals have reached critical ICU capacity at some point over the past three months. Hospital located in areas with fewer insured people were more likely to reach critical ICU capacity. At an institutional level, for-profit hospitals, rural hospitals, and those that have less baseline staffing of intensivists and nurses were more likely to reach critical ICU capacity.
Meaning The COVID-19 pandemic appears to be disproportionately straining ICUs with fewer resources and staff, setting up a substantial risk to widen disparities in access to care for already underserved populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This work was under the oversight of the Harvard School of Public Health IRB but uses only public data and is exempt.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
HHS Protect Data is available online
